Literature DB >> 25503530

External validation of scoring instruments for evaluating pediatric resuscitation.

Arielle Levy1, Aaron Donoghue, Benoit Bailey, Nathan Thompson, Olivier Jamoulle, Robert Gagnon, Jocelyn Gravel.   

Abstract

INTRODUCTION: Although many methods have been proposed to assess clinical performance during resuscitation, robust and generalizable metrics are still lacking. Further research is necessary to develop validated clinical performance assessment tools and show an improvement in outcomes after training. We aimed to establish evidence for validity of a previously published scoring instrument--the Clinical Performance Tool (CPT)--designed to evaluate clinical performance during simulated pediatric resuscitations.
METHODS: This was a prospective experimental trial performed in the simulation laboratory of a pediatric tertiary care facility, with a pretest/posttest design that assessed residents before and after pediatric advanced life support (PALS) certification. Thirteen postgraduate year 1 (PGY1) and 11 PGY3 pediatric residents completed 5 simulated pediatric resuscitation scenarios each during 2 consecutive sessions; between the 2 sessions, they completed a full PALS certification course. All sessions were video recorded. Sessions were scored by raters using the CPT; total scores were expressed as a percentage of maximum points possible for each scenario. Validity evidence was established and interpreted according to Messick's framework. Evidence regarding relations to other variables was assessed by calculating differences in scores between pre-PALS and post-PALS certification and PGY1 and PGY3 using a repeated-measures analysis of variance test. Internal structure evidence was established by assessing interrater reliability using intraclass correlation coefficients (ICCs) for each scenario, a G-study, and a variance component analysis of individual measurement facets (scenarios, raters, and occasions) and associated interactions.
RESULTS: Overall scores for the entire study cohort improved by 10% after PALS training. Scores improved by 9.9% (95% confidence interval [CI], 4.5-15.4) for the pulseless nonshockable arrest (ICC, 0.85; 95% CI, 0.74-0.92), 14.6% (95% CI, 6.7-22.4) for the pulseless shockable arrest (ICC, 0.98; 95% CI, 0.96-0.99), 4.1% (95% CI, -4.5 to 12.8) for the dysrhythmias (ICC, 0.92; 95% CI, 0.87-0.96), 18.4% (95% CI, 9.7-27.1) for the respiratory scenario (ICC, 0.97; 95% CI, 0.95-0.98), and 5.3% (95% CI, -1.4 to 2.0) for the shock scenarios (ICC, 0.94; 95% CI, 0.90-0.97). There were no differences between PGY1 and PGY3 scores before or after the PALS course. Reliability of the instrument was acceptable as demonstrated by a mean ICC of 0.95 (95% CI, 0.94-0.96). The G-study coefficient was 0.94. Most variance could be attributed to the subject (57%). Interactions between subject and scenario and subject and occasion were 9.9% and 1.4%, respectively, and variance attributable to rater was minimal (0%).
CONCLUSIONS: Pediatric residents improved scores on CPT after completion of a PALS course. Clinical Performance Tool scores are sensitive to the increase in skills and knowledge resulting from such a course but not to learners' levels. Validity evidence from scores for the CPT confirms implementation in new contexts and partially supports internal structure. More evidence is required to further support internal structure and especially to support relations with other variables and consequence evidence. Additional modifications should be made to the CPT before considering its use for high-stakes certification such as PALS.

Entities:  

Mesh:

Year:  2014        PMID: 25503530     DOI: 10.1097/SIH.0000000000000052

Source DB:  PubMed          Journal:  Simul Healthc        ISSN: 1559-2332            Impact factor:   1.929


  7 in total

1.  Assessment Tools for Use During Anesthesia-Centric Pediatric Advanced Life Support Training and Evaluation.

Authors:  Scott C Watkins; Paul J Nietert; Elisabeth Hughes; Eric T Stickles; Tracy E Wester; Matthew D McEvoy
Journal:  Am J Med Sci       Date:  2016-10-03       Impact factor: 2.378

2.  Rapid cycle deliberate practice improves and sustains paediatric resident PALS performance.

Authors:  Nathan D Swinger; Chrystal Rutledge; Stacy Gaither; Amber Q Youngblood; Jerri Lynn Zinkan; Nancy M Tofil
Journal:  BMJ Simul Technol Enhanc Learn       Date:  2020-09-03

3.  Implementation and evaluation of a shock curriculum using simulation in Manila, Philippines: a prospective cohort study.

Authors:  Sarah E Gardner Yelton; Lorelie Cañete Ramos; Carolyn J Reuland; Paula Pilar G Evangelista; Nicole A Shilkofski
Journal:  BMC Med Educ       Date:  2022-08-05       Impact factor: 3.263

4.  CPR coaching during cardiac arrest improves adherence to PALS guidelines: a prospective, simulation-based trial.

Authors:  Michael Buyck; Yasaman Shayan; Jocelyn Gravel; Elizabeth A Hunt; Adam Cheng; Arielle Levy
Journal:  Resusc Plus       Date:  2020-12-16

5.  Assessment of laypersons' paediatric basic life support and foreign body airway obstruction management skills: a validity study.

Authors:  Asbjørn Hasselager; Doris Østergaard; Tim Kristensen; Claus Sønderskov; Cathrine Bohnstedt; Torsten L B Lauritsen; Lars Konge; Martin G Tolsgaard
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-09-06       Impact factor: 2.953

6.  Development and Usability of a Novel Interactive Tablet App (PediAppRREST) to Support the Management of Pediatric Cardiac Arrest: Pilot High-Fidelity Simulation-Based Study.

Authors:  Francesco Corazza; Deborah Snijders; Marta Arpone; Valentina Stritoni; Francesco Martinolli; Marco Daverio; Maria Giulia Losi; Luca Soldi; Francesco Tesauri; Liviana Da Dalt; Silvia Bressan
Journal:  JMIR Mhealth Uhealth       Date:  2020-10-01       Impact factor: 4.773

7.  Improving the Quality of Evaluation Data in Simulation-Based Healthcare Improvement Projects: A Practitioner's Guide to Choosing and Using Published Measurement Tools.

Authors:  Chiara M Santomauro; Andrew Hill; Tara McCurdie; Hannah L McGlashan
Journal:  Simul Healthc       Date:  2020-10       Impact factor: 2.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.